D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years
Titel:
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years
Auteur:
Turkova, Anna Chan, Man K. Kityo, Cissy Kekitiinwa, Adeodata R. Musoke, Philippa Violari, Avy Variava, Ebrahim Archary, Moherndran Cressey, Tim R. Chalermpantmetagul, Suwalai Sawasdichai, Kanokkorn Ounchanum, Pradthana Kanjanavanit, Suparat Srirojana, Sakulrat Srirompotong, Ussanee Welch, Steven Bamford, Alasdair Epalza, Cristina Fortuny, Clàudia Colbers, Angela Nastouli, Eleni Walker, Simon Carr, Dan Conway, Magda Spyer, Moira J. Parkar, Nazia White, Iona Nardone, Alessandra Thomason, Margaret J. Ferrand, Rashida A. Giaquinto, Carlo Ford, Deborah